MedTrace Logo

Assess Safety, Efficacy and Usability of Application for Atrial Fibrillation Vocal Marker

NCT04613544 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2020-11-03

No results posted yet for this study

Summary

Voice Assist Arrhythmia Monitoring (VAAM) is an application running on smartphones and/or landline phones that performs vocal tests for the monitoring of abnormalities in the heart rhythm.

Conditions

Interventions

DEVICE

Voice Assist Arrhythmia Monitoring (VAAM)

application flag the potential occurrence of irregular heart rhythms suggestive of atrial fibrillation (AF) and notify to further investigate the occurrence of the suspected AF episode by prompting user to initiate ECG test to confirm.

Sponsors & Collaborators

  • Cardiokol Ltd

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-07
Primary Completion
2021-08-31
Completion
2021-12-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04613544 on ClinicalTrials.gov